News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Trial Shows Berlin Heart, Inc.’s EXCOR® Pediatric Ventricular Assist Device (VAD) Successfully Bridged 90% of Children with Severe Heart Failure Who Were Waiting for a Heart Transplant



11/16/2011 11:03:42 AM

THE WOODLANDS, Texas & BERLIN--(BUSINESS WIRE)--The Berlin Heart Group announced today that clinical trial data were presented this morning at the “Scientific Sessions 2011” annual meeting of the American Heart Association (AHA). These data showed that, in a clinical trial of children with severe heart failure who were waiting for a heart transplant, 90% of patients in the primary cohort of the study were successfully bridged to a heart transplant using Berlin Heart’s EXCOR® Pediatric Ventricular Assist Device (VAD).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES